“…Evaluation of the prognostic value of platelet to lymphocyte ratio in patients with hepatocellular carcinoma such as platelet-lymphocyte ratio (PLR), neutrophillymphocyte ratio (NLR), C-reactive protein have been proven as valuable prognostic factors in multiple gastrointestinal cancers including pancreatic ductal adenocarcinoma, colorectal cancer and gastric cancer (7,(9)(10)(11)(13)(14)(15)(16). In HCC however, the results were still conflicting regarding the prognostic value of PLR to predict overall survival and the optimal cut-off of PLR remains unclear (11,(17)(18)(19)(20).…”